Home › NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone
 

Keywords :   


NASH Clinical Trail Surpasses 25% Patient Recruitment Milestone

2015-11-18 20:49:12| Agriculture - Topix.net

Australian biopharmaceutical Company Immuron Limited is pleased to announce that the Company's Phase IIb, the IMM-124E clinical trial for the treatment of NASH , has successfully passed its 25% recruitment milestone with 35 patients having been successfully randomized into either arms. Immuron continues to drive its NASH clinical trial recruitment to meet its enrollment goal of 120 biopsy-proven NASH subjects by June 2016.

Tags: patient clinical trail recruitment

Category:Agriculture and Forestry

Latest from this category

All news
14.11Farm Progress America, Nov. 14, 2024
14.11Farm Progress America, Nov. 14, 2024
13.11Key considerations for winter managing weaned calves
13.11Maple Leaf Foods makes significant strides in Q3, driven by prepared meats business
13.11Potential for U.S. agriculture to be a net-negative greenhouse gas emitter
13.11Potential for U.S. agriculture to be a net-negative greenhouse gas emitter
13.11Will Trump tariffs benefit agriculture trade?
13.11Is hybrid rye the answer for organic production?
Agriculture and Forestry »
14.11NERF RAIDER CS-35 N-STRIKE 35
14.11Epiphone SGG400
14.11PHILWOOD×H PLUS SON* track wheel
14.1125th
14.1110.5
14.11
14.11JAKO 96
14.11
More »